(Q28258882)

2

object named as

William J Sandborn

0 references

Brian G. Feagan

1

object named as

Brian G Feagan

0 references

author name string

Timothy Niecko

4

0 references

Jeffrey White

The American Journal of Gastroenterology

5

0 references

language of work or name

English

0 references

publication date

December 2007

0 references

published in

0 references

volume

102

0 references

issue

12

0 references

page(s)

2737-46

0 references

cites work

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2007.01508.X

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2007.01508.X

Natalizumab for active Crohn's disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2007.01508.X

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2007.01508.X

The MOS 36-ltem Short-Form Health Survey (SF-36)

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2007.01508.X

Long-term evolution of disease behavior of Crohn's disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

A controlled double blind study of azathioprine in the management of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

Maintenance therapy for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

Measurement of health status. Ascertaining the minimal clinically important difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

The UK IBDQ-a British version of the inflammatory bowel disease questionnaire. development and validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

Inverse correlation of each functional status scale of the SF-36 with degree of disease activity in systemic lupus erythematosus (m-SLAM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

The EQ-5D--a generic quality of life measure--is a useful instrument to measure quality of life in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X

Methotrexate for the Treatment of Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01508.X